Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections

Journal of Clinical Virology

Volumn 52, Issue SUPPL. 1, 2011, Pages

  Masciotra, Silvina ^a   McDougal, J Steven ^a   Feldman, Jane ^a   Sprinkle, Patrick ^a   Wesolowski, Laura ^a   Owen, S Michele ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Algorithm; Diagnostic; HIV 1; Laboratory

Indexed keywords

ALGORITHM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; WESTERN BLOTTING;

ALGORITHMS; BLOTTING, WESTERN; EARLY DIAGNOSIS; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOASSAY; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; UNITED STATES;

EID: 83155192222     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.09.011     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989, 38(S7):1-7.
2. Constantine N.T., Saville R.D., Dax E.M. Retroviral testing and quality assurance 2005, MedMira Laboratories, Halifax, Nova Scotia, Canada, p.1-701.
3. Mylonakis E., Paliou M., Lally M., Flaningan T.P., Rich J.D. Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches. Am J Med 2000, 109:568-576.
4. O'Brien T.R., George J.R., Epstein J.S., Schochetman G. Testing for antibodies to human immunodeficiency virus type 2 in the United States. MMWR Recommend Rep 1992, 41(RR12):1-9.
5. Bush M.P., Hecht F.R. Nucleic acid amplification testing for diagnosis of acute HIV infections: has the time come?. AIDS 2005, 19:1317-1319.
6. Nguyen K.-A., Busch M.P. Evolving strategies for diagnosing human immunodeficiency virus infection. Am J Med 2000, 109:595-597.
7. Weber B. Screening of HIV infection: role of molecular and immunological assays. Expert Rev Mol Diagn 2006, 6:399-411.
8. O'Connell R.J., Peel S.A. Multispot™ HIV-1/HIV-2 rapid test: advantages over the other rapid HIV tests. Expert Rev Mol Diagn 2007, 7:499-505.
9. Stevens W.S., Noble L., Berrie L., Sarang S., Scott L.E. Ultra-high through-put, automated nucleic acid detection of HIV for infant diagnosis using the Gen-Probe Aptima HIV-1 screening assay. J Clin Microbiol 2009, 47:2465-2469.
10. Koch W.H., Sullivan P.S., Roberts C., Francis K., Downing R., Mastro T.D., et al. Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variants. J Clin Microbiol 2001, 39:1017-1020.
11. Cohen M.S., Gay C.L., Bush M.P., Hecht F.M. The detection of acute HIV infection. J Infect Dis 2010, 202(S2):S270-S277.
12. Eshleman S.H., Khaki L., Laeyendecker O., Piwowar-Manning E., Johnson-Lewis L., Husnik M., et al. Detection of individuals with acute HIV-1 infection using the architect HIV Ag/Ab combo assay. J Acquir Immune Defic Syndr 2009, 52:121-124.
13. Pandori M.W., Hackett J., Louie B., Vallari A., Dowling T., Liska S., et al. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J Clin Microbiol 2009, 47:2639-2642.
14. Kim S., Lee J.-H., Choi J.Y., Kim J.M., Kim H.-S. False-positive rate of a " fourth-generation" HIV antigen/antibody combination assay in an area of low HIV prevalence. Clin Vaccine Immunol 2010, 17:1642-1644.
15. Holguín A., Gutiérrez M., Portocarrero N., Rivas P., Baquero M. Performance of OraQuick Advance rapid HIV-1/2 antibody test for detection of antibodies in oral fluid and serum/plasma in HIV-1 + subjects carrying different HIV-1 subtypes and recombinant variants. J Clin Microbiol 2009, 45:150-152.
16. Owen M., Patel P., Wesolowski L., Vallari A., Brennan C., Devare S., et al. Evaluation of the Abbott ARCHITECT Ag/Ab Combo assay, and antigen/antibody combination test: implications for US HIV testing programs. Program and abstracts of the 16th conference on retroviruses and opportunistic infections 2009, Abstract 991.
17. Barbe F., Kelin M., Badonnel Y. Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and Western blot. Ann Biol Clin 1994, 52:341-345.
18. Constantine N.T., van der Groen G., Belsey E., Tamashiro H. Sensitivity of HIV antibody assays as determined by seroconversion panels. AIDS 1994, 8:1715-1720.
19. Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schummacher R.T., Peddada L., et al. Dynamics of the HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003, 17:1871-1879.
20. Louie B., Pandori M., Wong E., Klausner J.D., Liska S. Use of an acute seroconversion panel to evaluate a third-generation enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies relative to multiple other assays. J Clin Microbiol 2006, 44:1856-1858.
21. Wawer M.J., Gray R.H., Sewankambo N.K., Serwadda D., Li X., Laeyendecker O., et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005, 191:1403-1409.
22. Hollingsworth T.D., Anderson R.M., Fraser C. HIV-1 transmission, by stage of infection. J Infect Dis 2008, 198:687-693.
23. Association of Public Health Laboratories and the Centers for Disease Control & Prevention. HIV testing algorithms-a status report. Available: http://www.aphl.org/aphlprograms/infectious/hiv/Documents/StatusReportFINAL.pdf.
24. Pandori M.W., Branson B.M. 2010 HIV diagnostics conference. Expert Rev Anti Infect Ther 2010, 8:631-633.
25. Bentsen C., Wells P., Staswick L., Martin E., Branson B., Constantine N., et al. Multistate evaluation of BIO-RAD Multispot HIV-1/HIV-2 rapid test to detect and differentiate HIV-1 from HIV-2 and as a stand-alone multi-test HIV-1 Algorithm based on separate recombinant and peptide antigent spots 2005, Available:. http://www.hivtestingconference.org/hivtesting2005/PA1.htm.
26. Dragavon J., Gallardo C., Espinosa E., Ortega J.P., Harb S., Steckler J., et al. Use of Multispot HIV-1/HIV-2 rapid test to confirm HIV-1/HIV-2 Plus O Enzyme Immunoassay results, shorten reporting time for HIV testing and identify cryptic HIV-2 infection. HIV diagnostics conference 2010, Available:. http://www.hivtestingconference.org/PDF/Presentations/Coombs.pdf.
27. Owen S.M., Yang C., Spira T., Ou C.Y., Pau C.P., Parekh B.S., et al. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licencesed in the United States. J Clin Microbiol 2008, 46:1588-1595.
28. Patel P., Mackellar D., Simmons P., Uniyal A., Gallagher K., Bennet B., et al. Detecting acute human immunodeficiency virus infection using 3 different screening immunoassays and nucleic acid amplification testing for human immunodeficiency virus RNA, 2006-2008. Arch Intern Med 2010, 170:66-74.